Contact Us
Drug Search Results
More Filters [+]

Ketanserin

Alternative Names: ketanserin, sufrexal
Latest Update: 2024-12-16
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: 5-HT2 Antagonist,GPIIb/IIIa Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Intravenous,Sublingual

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Dominican Republic | Germany | Ireland | Italy | Mexico | Portugal | Taiwan | United Kingdom | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: Medisch Centrum Leeuwarden
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Ketanserin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Other|Hypertension

Phase 3: Sepsis|Kidney Diseases|Shock, Septic|Acute Kidney Injury

Phase 1: Consciousness Disorders|Depressive Disorder, Treatment-Resistant|Headache Disorders, Primary|Psychotic Disorders|Cluster Headache|Depressive Disorder

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
LBL

P1

Recruiting

Depressive Disorder, Treatment-Resistant|Consciousness Disorders|Cluster Headache|Psychotic Disorders|Headache Disorders, Primary

2025-06-30

L-Ket

P1

Completed

Depressive Disorder

2021-08-28

KoPTaL

P4

Unknown status

Hypertension

2019-04-01

KoPTaL

P4

Active, not recruiting

Other

2019-03-02

Recent News Events

Date

Type

Title

05/04/2024

PubMed

 Psilocybin reduces alcohol self-administration via selective left nucleus accumbens activation in rats.

04/22/2024

PubMed

 Examination of the effects of vitexin and vitexin-loaded solid lipid nanoparticles on neuropathic pain and possible mechanisms of action.

04/21/2024

PubMed

 Ligand bias and inverse agonism on 5-HT2A receptor-mediated modulation of G protein activity in post-mortem human brain.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions